Glargine

Efficacy and Safety of Dapagliflozin for the Hospital Management of Patients With Type 2 Diabetes

SITAgliptin Plus GLARgine to Glycemic Control in the Hospital Setting (SITAGLAR-H)

RISE Adult Medication Study

RISE Pediatric Medication Study

Outcome of Glargine Insulin in Renal Impairment Patients With Diabetic Ketoacidosis

Early Glargine (Lantus) in DKA Management in Children With Type 1 Diabetes

Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharged Patients With Type 2 Diabetes

Study for Beinaglutide Versus Glargine Therapy in Glycemic Variability of Type 2 Diabetes Mellitus

Remission Through Early Monitored Insulin Therapy - Duration Month

Intermediate and Long Acting Insulin Young Children Type 1 Diabetes.

Early Administration of Long-acting Insulin Treatment of Diabetic Ketoacidosis in Pediatric Type 1 Diabetes

Use of NPH Versus Basal Bolus Insulin for Steroid Induced Hyperglycemia

Effectiveness of Adding Subcutaneous Long-acting Glargine to Insulin Drip Therapy Compared With Standard Insulin Drip Therapy

Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH

Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes

Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory Variables

Comparison on Efficacy and Safety of Three Inpatient Insulin Therapy in Type2 DM

Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes

Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 Diabetes

Satisfaction of Treatment Among Elderly Patients With Insulin Therapy